Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Muscle & Nerve|April 6, 2007
Matrix metalloproteinases in neuromuscular diseaseSusanne Renaud, David Leppert
Annals of Neurology|February 21, 2013
On being a neurologist in industryDavid Leppert, Robert Glanzman
Neurology|December 10, 2003
Stimulus recognition and its relationship to the cerebral event-related potentialDavid Leppert, Douglas S Goodin, Michael J Aminoff
Cellular and Molecular Life Sciences : CMLS|June 8, 2019
MMPs and ADAMs in neurological infectious diseases and multiple sclerosisLukas Muri, David Leppert, Denis Grandgirard, et al.
Infection and Immunity|February 5, 2014
Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitisFabian D Liechti, Denis Grandgirard, David Leppert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Fluid biomarker and electrophysiological outcome measures for progressive MS trialsChristian Barro, Letizia Leocani, David Leppert, et al.
The Lancet. Neurology|September 27, 2025
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applicationsTanuja Chitnis, Roberta Magliozzi, Ahmed Abdelhak, et al.
Journal of Neuroinflammation|April 19, 2015
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitisFabian D Liechti, Fabian Bächtold, Denis Grandgirard, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 26, 2020
Serum neurofilament light chains in MS: Association with the Timed Up and GoGilles Allali, Jens Kuhle, Gautier Breville, et al.
Pageof 16